Sirolimus

Phase 1/2Completed

0 watching 0 views this week⚡ Active

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Desmoid Tumor

Conditions

Desmoid Tumor

Trial Timeline

Feb 1, 2014 → Dec 22, 2021

NCT ID

NCT01265030

About Sirolimus

Sirolimus is a phase 1/2 stage product being developed by Pfizer for Desmoid Tumor. The current trial status is completed. This product is registered under clinical trial identifier NCT01265030. Target conditions include Desmoid Tumor.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (20)

NCT ID	Phase	Status	Start	Completion	Indication
NCT04094675	Phase 2	Completed	Sep 16, 2019	Jun 5, 2025	PTEN Gene Mutation
NCT03047980	Phase 2/3	Completed	Jan 1, 2017	Oct 27, 2020	Sturge-Weber Syndrome
NCT01265030	Phase 1/2	Completed	Feb 1, 2014	Dec 22, 2021	Desmoid Tumor
NCT01595841	Phase 2	Completed	Dec 1, 2011	Mar 1, 2022	End Stage Renal Disease
NCT01680250	Phase 2/3	UNKNOWN	Sep 1, 2011	Aug 1, 2015	Polycystic Kidney Diseases
NCT00484094	Pre-clinical	Completed	Jul 1, 2011	Jun 1, 2015	Kidney Transplantation
NCT01236378	Phase 1	Completed	Dec 1, 2010	Apr 1, 2011	Transplant Rejection
NCT00999258	Approved	UNKNOWN	Sep 1, 2009	Jun 1, 2011	Glomerular Filtration Rate
NCT00697112	Pre-clinical	Completed	May 1, 2008	Dec 1, 2012	Renal Transplantation
NCT00555373	Pre-clinical	Completed	Nov 1, 2007	Nov 1, 2012	Renal Transplant
NCT02117596	Pre-clinical	Completed	Nov 1, 2007	Nov 1, 2012	Renal Transplant
NCT00866879	Approved	Completed	Jun 1, 2007	Mar 1, 2019	Renal Transplant Rejection
NCT00282217	Approved	Completed	Aug 1, 2006	—	Kidney Failure
NCT00275522	Approved	Completed	Dec 1, 2005	Dec 1, 2007	Kidney Transplant
NCT00490789	Phase 2	UNKNOWN	Oct 1, 2005	Sep 1, 2009	Tuberous Sclerosis
NCT00137345	Phase 3	Terminated	Jun 1, 2005	Aug 1, 2006	Kidney Transplant
NCT00170053	Phase 1	Completed	Jun 1, 2005	Sep 1, 2008	Kidney Diseases
NCT00195195	Pre-clinical	Completed	Jan 1, 2005	Jun 1, 2008	Transplantation
NCT00189202	Phase 2/3	Completed	Aug 1, 2004	Jul 1, 2008	End Stage Renal Disease
NCT00188955	Approved	Completed	Mar 1, 2004	Oct 1, 2008	Kidney Transplantation

Competing Products

1 competing product in Desmoid Tumor

See all competitors

Product	Company	Stage	Hype Score
AL102	Immunome	Phase 2/3	60

Other Products from Pfizer